Astellas Pharma US, Inc. Announces Availability Of MYCAMINE(R) 100mg Vial
Sat, 13 Jan 2007 08:00 AM EST
... Astellas Pharma US, Inc. announced today the availability of their antifungal agent MYCAMINE(R) (micafungin sodium) for injection in a 100mg vial format. Approved in 2005 for the treatment of patients with esophageal candidiasis and prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation, MYCAMINE(R) was previously only available in a 50mg vial. [click link for full article] ...

Not Signed In -


